BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Savoji H, Mohammadi MH, Rafatian N, Toroghi MK, Wang EY, Zhao Y, Korolj A, Ahadian S, Radisic M. Cardiovascular disease models: A game changing paradigm in drug discovery and screening. Biomaterials 2019;198:3-26. [PMID: 30343824 DOI: 10.1016/j.biomaterials.2018.09.036] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Moyle LA, Jacques E, Gilbert PM. Engineering the next generation of human skeletal muscle models: From cellular complexity to disease modeling. Current Opinion in Biomedical Engineering 2020;16:9-18. [DOI: 10.1016/j.cobme.2020.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
2 Toroghi MK, Cluett WR, Mahadevan R. A multi-scale model for low-density lipoprotein cholesterol (LDL-C) regulation in the human body: Application to quantitative systems pharmacology. Computers & Chemical Engineering 2019;130:106507. [DOI: 10.1016/j.compchemeng.2019.06.032] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
3 Yao Y, Li A, Wang S, Lu Y, Xie J, Zhang H, Zhang D, Ding J, Wang Z, Tu C, Shen L, Zhuang L, Zhu Y, Gao C. Multifunctional elastomer cardiac patches for preventing left ventricle remodeling after myocardial infarction in vivo. Biomaterials 2022;282:121382. [DOI: 10.1016/j.biomaterials.2022.121382] [Reference Citation Analysis]
4 Fontana F, Figueiredo P, Martins JP, Santos HA. Requirements for Animal Experiments: Problems and Challenges. Small 2021;17:2004182. [DOI: 10.1002/smll.202004182] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Dey SK, Saini M, Prabhakar P, Kundu S. Dopamine β hydroxylase as a potential drug target to combat hypertension. Expert Opinion on Investigational Drugs 2020;29:1043-57. [DOI: 10.1080/13543784.2020.1795830] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Miller DD. Machine Intelligence in Cardiovascular Medicine. Cardiology in Review 2020;28:53-64. [DOI: 10.1097/crd.0000000000000294] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
7 Liu G, David BT, Trawczynski M, Fessler RG. Advances in Pluripotent Stem Cells: History, Mechanisms, Technologies, and Applications. Stem Cell Rev Rep. 2020;16:3-32. [PMID: 31760627 DOI: 10.1007/s12015-019-09935-x] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 41.0] [Reference Citation Analysis]
8 Li H, Liu M, Wang X, Wang H, Mo X, Wu J. Nanofiber Configuration of Electrospun Scaffolds Dictating Cell Behaviors and Cell-scaffold Interactions. Chem Res Chin Univ 2021;37:456-63. [DOI: 10.1007/s40242-021-1024-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hoffman T, Antovski P, Tebon P, Xu C, Ashammakhi N, Ahadian S, Morsut L, Khademhosseini A. Synthetic Biology and Tissue Engineering: Toward Fabrication of Complex and Smart Cellular Constructs. Adv Funct Mater 2020;30:1909882. [DOI: 10.1002/adfm.201909882] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
10 Allijn I, Ribeiro M, Poot A, Passier R, Stamatialis D. Membranes for Modelling Cardiac Tissue Stiffness In Vitro Based on Poly(trimethylene carbonate) and Poly(ethylene glycol) Polymers. Membranes (Basel) 2020;10:E274. [PMID: 33022962 DOI: 10.3390/membranes10100274] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Tayyeb JZ, Popeijus HE, Mensink RP, Konings MCJM, Mulders KHR, Plat J. Amoxicillin Modulates ApoA-I Transcription and Secretion, Predominantly via PPARα Transactivation Inhibition. Int J Mol Sci 2019;20:E5967. [PMID: 31783518 DOI: 10.3390/ijms20235967] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Kjar A, McFarland B, Mecham K, Harward N, Huang Y. Engineering of tissue constructs using coaxial bioprinting. Bioact Mater 2021;6:460-71. [PMID: 32995673 DOI: 10.1016/j.bioactmat.2020.08.020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
13 Paloschi V, Sabater-Lleal M, Middelkamp H, Vivas A, Johansson S, van der Meer A, Tenje M, Maegdefessel L. Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases. Cardiovasc Res 2021:cvab088. [PMID: 33729461 DOI: 10.1093/cvr/cvab088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Solazzo M, O'Brien FJ, Nicolosi V, Monaghan MG. The rationale and emergence of electroconductive biomaterial scaffolds in cardiac tissue engineering. APL Bioeng 2019;3:041501. [PMID: 31650097 DOI: 10.1063/1.5116579] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
15 Meng X, Xing Y, Li J, Deng C, Li Y, Ren X, Zhang D. Rebuilding the Vascular Network: In vivo and in vitro Approaches. Front Cell Dev Biol 2021;9:639299. [PMID: 33968926 DOI: 10.3389/fcell.2021.639299] [Reference Citation Analysis]
16 Cavero I, Guillon J, Holzgrefe HH. Human organotypic bioconstructs from organ-on-chip devices for human-predictive biological insights on drug candidates. Expert Opinion on Drug Safety 2019;18:651-77. [DOI: 10.1080/14740338.2019.1634689] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
17 Sharma P, Wang X, Ming CLC, Vettori L, Figtree G, Boyle A, Gentile C. Considerations for the Bioengineering of Advanced Cardiac In Vitro Models of Myocardial Infarction. Small 2021;17:2003765. [DOI: 10.1002/smll.202003765] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Daly AC, Davidson MD, Burdick JA. 3D bioprinting of high cell-density heterogeneous tissue models through spheroid fusion within self-healing hydrogels. Nat Commun 2021;12:753. [PMID: 33531489 DOI: 10.1038/s41467-021-21029-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 21.0] [Reference Citation Analysis]
19 Zwartsen A, de Korte T, Nacken P, de Lange DW, Westerink RHS, Hondebrink L. Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings. J Mol Cell Cardiol 2019;136:102-12. [PMID: 31526813 DOI: 10.1016/j.yjmcc.2019.09.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
20 Wang EY, Kuzmanov U, Smith JB, Dou W, Rafatian N, Lai BFL, Lu RXZ, Wu Q, Yazbeck J, Zhang XO, Sun Y, Gramolini A, Radisic M. An organ-on-a-chip model for pre-clinical drug evaluation in progressive non-genetic cardiomyopathy. J Mol Cell Cardiol 2021;160:97-110. [PMID: 34216608 DOI: 10.1016/j.yjmcc.2021.06.012] [Reference Citation Analysis]
21 Ma Q, Ma H, Xu F, Wang X, Sun W. Microfluidics in cardiovascular disease research: state of the art and future outlook. Microsyst Nanoeng 2021;7:19. [PMID: 34567733 DOI: 10.1038/s41378-021-00245-2] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
22 Houson H, Hedrick A, Awasthi V. Drug-induced cardiomyopathy: Characterization of a rat model by [18F]FDG/PET and [99mTc]MIBI/SPECT. Animal Model Exp Med 2020;3:295-303. [PMID: 33532704 DOI: 10.1002/ame2.12136] [Reference Citation Analysis]
23 Rampoldi A, Singh M, Wu Q, Duan M, Jha R, Maxwell JT, Bradner JM, Zhang X, Saraf A, Miller GW, Gibson G, Brown LA, Xu C. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Toxicol Sci 2019;169:280-92. [PMID: 31059573 DOI: 10.1093/toxsci/kfz038] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
24 Kumar N, Sridharan D, Palaniappan A, Dougherty JA, Czirok A, Isai DG, Mergaye M, Angelos MG, Powell HM, Khan M. Scalable Biomimetic Coaxial Aligned Nanofiber Cardiac Patch: A Potential Model for "Clinical Trials in a Dish". Front Bioeng Biotechnol 2020;8:567842. [PMID: 33042968 DOI: 10.3389/fbioe.2020.567842] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Wei X, Zhuang L, Li H, He C, Wan H, Hu N, Wang P. Advances in Multidimensional Cardiac Biosensing Technologies: From Electrophysiology to Mechanical Motion and Contractile Force. Small 2020;16:e2005828. [PMID: 33230867 DOI: 10.1002/smll.202005828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Yu D, Cai Z, Li D, Zhang Y, He M, Yang Y, Liu D, Xie W, Li Y, Xiao W. Myogenic Differentiation of Stem Cells for Skeletal Muscle Regeneration. Stem Cells Int 2021;2021:8884283. [PMID: 33628275 DOI: 10.1155/2021/8884283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Donoghue L, Nguyen KT, Graham C, Sethu P. Tissue Chips and Microphysiological Systems for Disease Modeling and Drug Testing. Micromachines (Basel) 2021;12:139. [PMID: 33525451 DOI: 10.3390/mi12020139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Su X, Yuan C, Wang L, Chen R, Li X, Zhang Y, Liu C, Liu X, Liang W, Xing Y. The Beneficial Effects of Saffron Extract on Potential Oxidative Stress in Cardiovascular Diseases. Oxid Med Cell Longev 2021;2021:6699821. [PMID: 33542784 DOI: 10.1155/2021/6699821] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Wagner KT, Nash TR, Liu B, Vunjak-Novakovic G, Radisic M. Extracellular Vesicles in Cardiac Regeneration: Potential Applications for Tissues-on-a-Chip. Trends Biotechnol 2021;39:755-73. [PMID: 32958383 DOI: 10.1016/j.tibtech.2020.08.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
30 Filippo Buono M, von Boehmer L, Strang J, Hoerstrup SP, Emmert MY, Nugraha B. Human Cardiac Organoids for Modeling Genetic Cardiomyopathy. Cells 2020;9:E1733. [PMID: 32698471 DOI: 10.3390/cells9071733] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
31 Lee DH, Kim TM, Kim JK, Park C. ETV2/ER71 Transcription Factor as a Therapeutic Vehicle for Cardiovascular Disease. Theranostics 2019;9:5694-705. [PMID: 31534512 DOI: 10.7150/thno.35300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
32 Williams SK, Birla RK. Tissue engineering solutions to replace contractile function during pediatric heart surgery. Tissue Cell 2020;67:101452. [PMID: 33137707 DOI: 10.1016/j.tice.2020.101452] [Reference Citation Analysis]
33 [DOI: 10.1101/2020.05.21.103127] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
34 Rothbauer M, Bachmann BEM, Eilenberger C, Kratz SRA, Spitz S, Höll G, Ertl P. A Decade of Organs-on-a-Chip Emulating Human Physiology at the Microscale: A Critical Status Report on Progress in Toxicology and Pharmacology. Micromachines (Basel) 2021;12:470. [PMID: 33919242 DOI: 10.3390/mi12050470] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Wang EY, Rafatian N, Zhao Y, Lee A, Lai BFL, Lu RX, Jekic D, Davenport Huyer L, Knee-Walden EJ, Bhattacharya S, Backx PH, Radisic M. Biowire Model of Interstitial and Focal Cardiac Fibrosis. ACS Cent Sci 2019;5:1146-58. [PMID: 31403068 DOI: 10.1021/acscentsci.9b00052] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
36 Barteková M, Adameová A, Görbe A, Ferenczyová K, Pecháňová O, Lazou A, Dhalla NS, Ferdinandy P, Giricz Z. Natural and synthetic antioxidants targeting cardiac oxidative stress and redox signaling in cardiometabolic diseases. Free Radical Biology and Medicine 2021;169:446-77. [DOI: 10.1016/j.freeradbiomed.2021.03.045] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
37 Zuppinger C. 3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications. Front Cardiovasc Med 2019;6:87. [PMID: 31294032 DOI: 10.3389/fcvm.2019.00087] [Cited by in Crossref: 49] [Cited by in F6Publishing: 45] [Article Influence: 16.3] [Reference Citation Analysis]
38 Rodriguez-garcia A, Oliva-ramirez J, Bautista-flores C, Hosseini S. 3D In Vitro Human Organ Mimicry Devices for Drug Discovery, Development, and Assessment. Advances in Polymer Technology 2020;2020:1-41. [DOI: 10.1155/2020/6187048] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Kim J, Shanmugasundaram A, Lee DW. Enhancement of cardiac contractility using gold-coated SU-8 cantilevers and their application to drug-induced cardiac toxicity tests. Analyst 2021;146:6768-79. [PMID: 34642716 DOI: 10.1039/d1an01337h] [Reference Citation Analysis]
40 Liu Y, Chakraborty S, Direksilp C, Scheiger JM, Popova AA, Levkin PA. Miniaturized droplet microarray platform enables maintenance of human induced pluripotent stem cell pluripotency. Mater Today Bio 2021;12:100153. [PMID: 34765963 DOI: 10.1016/j.mtbio.2021.100153] [Reference Citation Analysis]
41 Shin HS, Shin HH, Shudo Y. Current Status and Limitations of Myocardial Infarction Large Animal Models in Cardiovascular Translational Research. Front Bioeng Biotechnol 2021;9:673683. [PMID: 33996785 DOI: 10.3389/fbioe.2021.673683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Parrotta EI, Lucchino V, Scaramuzzino L, Scalise S, Cuda G. Modeling Cardiac Disease Mechanisms Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Progress, Promises and Challenges. Int J Mol Sci 2020;21:E4354. [PMID: 32575374 DOI: 10.3390/ijms21124354] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
43 Tani H, Tohyama S. Human Engineered Heart Tissue Models for Disease Modeling and Drug Discovery. Front Cell Dev Biol 2022;10:855763. [DOI: 10.3389/fcell.2022.855763] [Reference Citation Analysis]
44 Simon LR, Masters KS. Disease-inspired tissue engineering: Investigation of cardiovascular pathologies. ACS Biomater Sci Eng 2020;6:2518-32. [PMID: 32974421 DOI: 10.1021/acsbiomaterials.9b01067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
45 Cho KW, Lee WH, Kim B, Kim D. Sensors in heart-on-a-chip: A review on recent progress. Talanta 2020;219:121269. [DOI: 10.1016/j.talanta.2020.121269] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
46 Zhao Y, Rafatian N, Wang EY, Wu Q, Lai BFL, Lu RX, Savoji H, Radisic M. Towards chamber specific heart-on-a-chip for drug testing applications. Adv Drug Deliv Rev 2020;165-166:60-76. [PMID: 31917972 DOI: 10.1016/j.addr.2019.12.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
47 Goedel A, Grote Beverborg N, Sahara M, Chien KR. In search of the next super models. EMBO Mol Med 2019;11:e11502. [PMID: 31736275 DOI: 10.15252/emmm.201911502] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Gähwiler EKN, Motta SE, Martin M, Nugraha B, Hoerstrup SP, Emmert MY. Human iPSCs and Genome Editing Technologies for Precision Cardiovascular Tissue Engineering. Front Cell Dev Biol 2021;9:639699. [PMID: 34262897 DOI: 10.3389/fcell.2021.639699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
49 Sarma H, Upadhyaya M, Gogoi B, Phukan M, Kashyap P, Das B, Devi R, Sharma HK. Cardiovascular Drugs: an Insight of In Silico Drug Design Tools. J Pharm Innov. [DOI: 10.1007/s12247-021-09587-w] [Reference Citation Analysis]
50 Hnatiuk AP, Briganti F, Staudt DW, Mercola M. Human iPSC modeling of heart disease for drug development. Cell Chem Biol 2021;28:271-82. [PMID: 33740432 DOI: 10.1016/j.chembiol.2021.02.016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Cobbaert CM, Althaus H, Begcevic Brkovic I, Ceglarek U, Coassin S, Delatour V, Deprez L, Dikaios I, Dittrich J, Hoofnagle AN, Kostner GM, Kronenberg F, Kuklenyik Z, Prinzing U, Vesper HW, Zegers I, Ruhaak LR; IFCC Working Group for Standardization of Apolipoproteins by Mass Spectrometry. Towards an SI-Traceable Reference Measurement System for Seven Serum Apolipoproteins Using Bottom-Up Quantitative Proteomics: Conceptual Approach Enabled by Cross-Disciplinary/Cross-Sector Collaboration. Clin Chem 2021;67:478-89. [PMID: 33331636 DOI: 10.1093/clinchem/hvaa239] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
52 Lamberto F, Peral-Sanchez I, Muenthaisong S, Zana M, Willaime-Morawek S, Dinnyés A. Environmental Alterations during Embryonic Development: Studying the Impact of Stressors on Pluripotent Stem Cell-Derived Cardiomyocytes. Genes (Basel) 2021;12:1564. [PMID: 34680959 DOI: 10.3390/genes12101564] [Reference Citation Analysis]
53 Sorop O, van de Wouw J, Chandler S, Ohanyan V, Tune JD, Chilian WM, Merkus D, Bender SB, Duncker DJ. Experimental animal models of coronary microvascular dysfunction. Cardiovasc Res 2020;116:756-70. [PMID: 31926020 DOI: 10.1093/cvr/cvaa002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
54 Jafari A, Ajji Z, Mousavi A, Naghieh S, Bencherif SA, Savoji H. Latest Advances in 3D Bioprinting of Cardiac Tissues. Adv Materials Technologies. [DOI: 10.1002/admt.202101636] [Reference Citation Analysis]
55 Yang Q, Xiao Z, Lv X, Zhang T, Liu H. Fabrication and Biomedical Applications of Heart-on-a-chip. Int J Bioprint 2021;7:370. [PMID: 34286153 DOI: 10.18063/ijb.v7i3.370] [Reference Citation Analysis]
56 Huang J, Feng Q, Wang L, Zhou B. Human Pluripotent Stem Cell-Derived Cardiac Cells: Application in Disease Modeling, Cell Therapy, and Drug Discovery. Front Cell Dev Biol 2021;9:655161. [PMID: 33869218 DOI: 10.3389/fcell.2021.655161] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
57 Vivas A, Ijspeert C, Pan JY, Vermeul K, den Berg A, Passier R, Keller SS, Meer AD. Generation and Culture of Cardiac Microtissues in a Microfluidic Chip with a Reversible Open Top Enables Electrical Pacing, Dynamic Drug Dosing and Endothelial Cell Co‐Culture. Adv Materials Technologies. [DOI: 10.1002/admt.202101355] [Reference Citation Analysis]
58 Ashammakhi N, Ahadian S, Xu C, Montazerian H, Ko H, Nasiri R, Barros N, Khademhosseini A. Bioinks and bioprinting technologies to make heterogeneous and biomimetic tissue constructs. Mater Today Bio 2019;1:100008. [PMID: 32159140 DOI: 10.1016/j.mtbio.2019.100008] [Cited by in Crossref: 126] [Cited by in F6Publishing: 108] [Article Influence: 42.0] [Reference Citation Analysis]
59 Harper RL, Ferrante EA, Boehm M. Development of vascular disease models to explore disease causation and pathomechanisms of rare vascular diseases. Semin Immunopathol 2022. [PMID: 35233690 DOI: 10.1007/s00281-022-00925-9] [Reference Citation Analysis]
60 Morsink M, Severino P, Luna-Ceron E, Hussain MA, Sobahi N, Shin SR. Effects of electrically conductive nano-biomaterials on regulating cardiomyocyte behavior for cardiac repair and regeneration. Acta Biomater 2021:S1742-7061(21)00771-6. [PMID: 34818579 DOI: 10.1016/j.actbio.2021.11.022] [Reference Citation Analysis]
61 James BD, Montoya N, Allen J. MechanoBioTester: A Decoupled Multistimulus Cell Culture Device for Studying Complex Microenvironments In Vitro. ACS Biomater Sci Eng 2020;6:3673-89. [PMID: 32704528 DOI: 10.1021/acsbiomaterials.0c00498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
62 Iachetta G, Colistra N, Melle G, Deleye L, Tantussi F, De Angelis F, Dipalo M. Improving reliability and reducing costs of cardiotoxicity assessments using laser-induced cell poration on microelectrode arrays. Toxicol Appl Pharmacol 2021;418:115480. [PMID: 33689843 DOI: 10.1016/j.taap.2021.115480] [Reference Citation Analysis]
63 Ashtari K, Nazari H, Ko H, Tebon P, Akhshik M, Akbari M, Alhosseini SN, Mozafari M, Mehravi B, Soleimani M, Ardehali R, Ebrahimi Warkiani M, Ahadian S, Khademhosseini A. Electrically conductive nanomaterials for cardiac tissue engineering. Adv Drug Deliv Rev 2019;144:162-79. [PMID: 31176755 DOI: 10.1016/j.addr.2019.06.001] [Cited by in Crossref: 46] [Cited by in F6Publishing: 33] [Article Influence: 15.3] [Reference Citation Analysis]
64 Maciag M, Wnorowski A, Bednarz K, Plazinska A. Evaluation of β-adrenergic ligands for development of pharmacological heart failure and transparency models in zebrafish. Toxicol Appl Pharmacol 2022;434:115812. [PMID: 34838787 DOI: 10.1016/j.taap.2021.115812] [Reference Citation Analysis]